Delayed Miscarriage Care Leads To Death Of Third Woman in Texas
November 26, 2024
Morning Briefing
Following complications from a miscarriage, 35-year-old Porsha Ngumezi suffered what more than a dozen doctors called a preventable death after not receiving a standard D&C procedure. More abortion news comes from Arizona, New York, Minnesota, and more.
‘Disappointing’: Cassava Sciences Ends Study Of Alzheimer’s Drug Simufilam
November 26, 2024
Morning Briefing
The company’s future now appears to be in flux, as simufilam was its only drug in clinical trials, The New York Times reported. Also: a Roche lung cancer drug has failed to improve survival; pharma companies’ net zero carbon goals; and more.
Feds Serve Warrant, Seize Phone Of Former Steward Health Care CEO
November 26, 2024
Morning Briefing
The Boston Globe reports on the widening investigation into Steward, including that federal investigators also visited another Steward executive and seized his phone, as well. Separately, the Globe explores how the Steward collapse is worsening ER overcrowding.
Two Years Into Philly’s Sugary Drink Tax, No Major Change In Kids’ Obesity
November 26, 2024
Morning Briefing
Among other news: Massachusetts law allows “sick leave” for miscarriages and failed adoptions, and the USDA has rejected Iowa’s request to send out food boxes to low-income families, putting summer food assistance for 240,000 kids in jeopardy.
Morning Briefing for Tuesday, November 26, 2024
November 26, 2024
Morning Briefing
Weight loss drug coverage, the MAHA movement, Medicaid, Medicare, trans health, medical debt, miscarriage care, and more.
Biden Proposes Weight Loss Drug Coverage By Medicare, Medicaid
November 26, 2024
Morning Briefing
HHS proposed a rule Tuesday that, if enacted, would expand access to anti-obesity medications like Wegovy, Ozempic, and Mounjaro to millions of Medicare and Medicaid beneficiaries. The regulation would not be finalized before Donald Trump takes office and could be blocked by the next HHS Secretary; nominee Robert F. Kennedy Jr. is a critic of such drugs.
First Edition: Tuesday, Nov. 26, 2024
November 26, 2024
Morning Briefing
Today’s early morning highlights from the major news organizations.
Florida’s Deloitte-Run Computer System Cut Off New Moms Entitled to Medicaid
By Daniel Chang Samantha Liss
November 26, 2024
KFF Health News Original
Florida discovered a glitch in its Deloitte-run Medicaid eligibility system. The problem, alleged in court testimony, led to new mothers wrongly losing their insurance coverage.
Indiana Hospitals Pull Merger Application After Pushback Over Monopoly Concerns
By Samantha Liss
November 26, 2024
KFF Health News Original
Two Indiana hospital rivals withdrew their application to merge after facing pushback from the Federal Trade Commission and the public.
Immigration Detention Center Contractor Sues Over California Health Inspections
By Vanessa G. Sánchez
November 26, 2024
KFF Health News Original
A private immigration detention center contractor has sued to block a California law allowing local public health officials to inspect facilities in response to allegations of medical neglect or unsanitary conditions.
Make America Healthy Again: An Unconventional Movement That May Have Found Its Moment
By Stephanie Armour
November 26, 2024
KFF Health News Original
Nonmainstream doctors and leaders in health business are wielding serious muscle in shaping the incoming Trump administration’s health policies and challenging prevailing thinking on public health, disease prevention, and chronic illness.
Qué es el movimiento para “Hacer a América saludable de nuevo” (MAHA)
By Stephanie Armour
November 26, 2024
KFF Health News Original
El regreso de Trump a la Casa Blanca ha dado un nuevo impulso a “Hacer América saludable de nuevo”, un movimiento controversial que desafía las ideas predominantes sobre la salud pública y las enfermedades crónicas.
Contratista de centro de detención de inmigrantes demanda a California por inspecciones de salud
By Vanessa G. Sánchez
November 26, 2024
KFF Health News Original
GEO Group podría expandir su control sobre las instalaciones de detención de inmigrantes ahora que el ex presidente Donald Trump ganó un segundo mandato.
Newest Perk On Company Health Insurance Plans: Menopause Benefits
November 25, 2024
Morning Briefing
The Washington Post reports on benefits popping up at an increasing number of companies, including time off, access to experts, flexible dress code, and more. Also: PFAS in breast milk, postpartum depression, a Virginia postnatal retreat, and more.
Surgeon General Pick Dr. Nesheiwat Gained Popularity At Fox News
November 25, 2024
Morning Briefing
Although Janette Nesheiwat is a family and emergency medicine physician, she has little public health experience. She supports vaccines but criticized government mandates during the covid pandemic. She also is critical of the standards of care for youth with gender dysphoria.
Trump’s Health Nominees Lack Infectious-Disease Expertise
November 25, 2024
Morning Briefing
The Washington Post reports on how the lack of tested experience among the hastily assembled team of experts for the next administration could be a problem if there is another pandemic or public health emergency.
Rollins Is Surprise Choice To Oversee USDA; HUD Nominee Is Ex-NFL Player
November 25, 2024
Morning Briefing
Donald Trump has picked Brooke Rollins, his former White House domestic policy adviser, to lead the Department of Agriculture, which runs the Supplemental Nutrition Assistance Program (SNAP) and Women, Infants, and Children (WIC). Meanwhile, Scott Turner has been selected to run the Department of Housing and Urban Development, which manages homelessness programs.
Facing Physician Shortage, CMS Opens 200 More Residency Slots
November 25, 2024
Morning Briefing
An estimated 70% of the slots were set aside for psychiatry or primary care. Other industry news is about Black doctors, UnitedHealth’s Medicare Advantage ratings, telehealth, at-home care, and more.
FDA Study Adds To Concerns That Asthma Drug Can Harm Mental Health
November 25, 2024
Morning Briefing
The FDA study finds that the popular asthma drug Singulair, sold generically as montelukast, can bind to brain receptors and is linked to severe mental health issues and suicide. However, more data is needed to confirm how the drug collects in the nervous system, the agency says.
